Sulfadoxine-Pyrimethamine + Amodiaquine Dispersible Tablets bulk supplier for pharma manufacturers

Sulfadoxine-Pyrimethamine + Amodiaquine Dispersible Tablets SP 250/12.5 mg + AQ 75 mg Suppliers & Bulk Manufacturers

Available Forms: Dispersible tablets, co-blistered

Available Strengths: SP 250/12.5 mg + AQ 75 mg

Pack Sizes: Monthly treatment blisters (SPAQ)

Reference Brands: SPAQ

SPAQ is a co-packed dispersible tablet set used for seasonal malaria chemoprevention in young children. PharmaTradz sources it for SMC campaigns, tenders and national programmes.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Sulfadoxine-Pyrimethamine + Amodiaquine Dispersible Tablets? List it or send an offer →

Product Description:

Seasonal malaria chemoprevention (SMC) gives young children a full course of antimalarials once a month during the rainy season, when most malaria cases and deaths occur. The medicines used are sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ), supplied together in one blister so the right doses go to the right child.

A course is one SP dose plus amodiaquine on day 1, and amodiaquine alone on days 2 and 3, repeated monthly for four or five months. Two strengths cover children aged 3–11 months and 12–59 months. The tablets dissolve in water and taste acceptable to children. SMC has greatly reduced malaria in the Sahel, and WHO now allows it wherever malaria is seasonal.

Sourcing notes. SPAQ is made by a small number of manufacturers in China, India and Africa, and is bought in very large volumes before each season through Global Fund, PMI, UNICEF and campaign partners that require WHO prequalification. Orders are placed months ahead of the rains, so timing is critical. Store below 30 °C, protected from moisture.

Sulfadoxine-Pyrimethamine + Amodiaquine Dispersible Tablets — third party manufacturing & bulk supply

Sulfadoxine-Pyrimethamine + Amodiaquine Dispersible Tablets SP 250/12.5 mg + AQ 75 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Sulfadoxine-Pyrimethamine + Amodiaquine Dispersible Tablets is supplied as Dispersible tablets, co-blistered — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Sulfadoxine-Pyrimethamine + Amodiaquine Dispersible Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Sulfadoxine-Pyrimethamine + Amodiaquine... →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Sulfadoxine-Pyrimethamine + Amodiaquine Dispersible Tablets is listed as Dispersible tablets, co-blistered in SP 250/12.5 mg + AQ 75 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Sulfadoxine-Pyrimethamine + Amodiaquine Dispersible Tablets is referenced against SPAQ. Reference brands are shown for identification only and remain the property of their respective trademark owners.